These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31652410)

  • 1. Prevention of HIV Transmission and the HPTN 052 Study.
    Cohen MS; Gamble T; McCauley M
    Annu Rev Med; 2020 Jan; 71():347-360. PubMed ID: 31652410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples.
    Chen YQ; Masse B; Wang L; Ou SS; Li X; Donnell D; McCauley M; Gamble T; Ribauldo HJ; Cohen MS; Fleming TR
    Contemp Clin Trials; 2012 Nov; 33(6):1280-6. PubMed ID: 22813645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.
    Dieffenbach CW
    Curr Opin HIV AIDS; 2012 Mar; 7(2):106-10. PubMed ID: 22227584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
    Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis.
    Sun L; Liu A; Li J; Shao Y; Li Q; Ye J; Zhang H; Li Z; Wang H
    BMC Infect Dis; 2020 Mar; 20(1):195. PubMed ID: 32138673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey.
    Cohen MS; McCauley M; Sugarman J
    Clin Trials; 2012 Jun; 9(3):340-7. PubMed ID: 22692805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
    Mujugira A; Celum C; Coombs RW; Campbell JD; Ndase P; Ronald A; Were E; Bukusi EA; Mugo N; Kiarie J; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):579-84. PubMed ID: 27070123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
    Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; van Lunzen J; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Asboe D; Viciana P; Gutiérrez F; Clotet B; Pradier C; Gerstoft J; Weber R; Westling K; Wandeler G; Prins JM; Rieger A; Stoeckle M; Kümmerle T; Bini T; Ammassari A; Gilson R; Krznaric I; Ristola M; Zangerle R; Handberg P; Antela A; Allan S; Phillips AN; Lundgren J;
    JAMA; 2016 Jul; 316(2):171-81. PubMed ID: 27404185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
    Yombi JC; Mertes H
    AIDS Rev; 2018; 20(3):131-140. PubMed ID: 30264827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic outcomes in early antiretroviral treatment: HPTN 052.
    Eshleman SH; Wilson EA; Zhang XC; Ou SS; Piwowar-Manning E; Eron JJ; McCauley M; Gamble T; Gallant JE; Hosseinipour MC; Kumarasamy N; Hakim JG; Kalonga B; Pilotto JH; Grinsztejn B; Godbole SV; Chotirosniramit N; Santos BR; Shava E; Mills LA; Panchia R; Mwelase N; Mayer KH; Chen YQ; Cohen MS; Fogel JM
    HIV Clin Trials; 2017 May; 18(3):100-109. PubMed ID: 28385131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
    Cohen MS; Chen YQ; McCauley M; Gamble T; Hosseinipour MC; Kumarasamy N; Hakim JG; Kumwenda J; Grinsztejn B; Pilotto JH; Godbole SV; Chariyalertsak S; Santos BR; Mayer KH; Hoffman IF; Eshleman SH; Piwowar-Manning E; Cottle L; Zhang XC; Makhema J; Mills LA; Panchia R; Faesen S; Eron J; Gallant J; Havlir D; Swindells S; Elharrar V; Burns D; Taha TE; Nielsen-Saines K; Celentano DD; Essex M; Hudelson SE; Redd AD; Fleming TR;
    N Engl J Med; 2016 Sep; 375(9):830-9. PubMed ID: 27424812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of transmission from HIV-infected individuals with HAART to their heterosexual serodiscordant partners.
    Del Romero J; Río I; Castilla J; Baza B; Paredes V; Vera M; Rodríguez C
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):666-72. PubMed ID: 25555636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
    Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
    PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
    PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of HIV-1 infection with early antiretroviral therapy.
    Cohen MS; Chen YQ; McCauley M; Gamble T; Hosseinipour MC; Kumarasamy N; Hakim JG; Kumwenda J; Grinsztejn B; Pilotto JH; Godbole SV; Mehendale S; Chariyalertsak S; Santos BR; Mayer KH; Hoffman IF; Eshleman SH; Piwowar-Manning E; Wang L; Makhema J; Mills LA; de Bruyn G; Sanne I; Eron J; Gallant J; Havlir D; Swindells S; Ribaudo H; Elharrar V; Burns D; Taha TE; Nielsen-Saines K; Celentano D; Essex M; Fleming TR;
    N Engl J Med; 2011 Aug; 365(6):493-505. PubMed ID: 21767103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV treatment as prevention and HPTN 052.
    Cohen MS; McCauley M; Gamble TR
    Curr Opin HIV AIDS; 2012 Mar; 7(2):99-105. PubMed ID: 22227585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.
    Jia Z; Mao Y; Zhang F; Ruan Y; Ma Y; Li J; Guo W; Liu E; Dou Z; Zhao Y; Wang L; Li Q; Xie P; Tang H; Han J; Jin X; Xu J; Xiong R; Zhao D; Li P; Wang X; Wang L; Qing Q; Ding Z; Chen RY; Liu Z; Shao Y
    Lancet; 2013 Oct; 382(9899):1195-203. PubMed ID: 23206835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
    Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; Degen O; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Raben D; Coll P; Antinori A; Nwokolo N; Rieger A; Prins JM; Blaxhult A; Weber R; Van Eeden A; Brockmeyer NH; Clarke A; Del Romero Guerrero J; Raffi F; Bogner JR; Wandeler G; Gerstoft J; Gutiérrez F; Brinkman K; Kitchen M; Ostergaard L; Leon A; Ristola M; Jessen H; Stellbrink HJ; Phillips AN; Lundgren J;
    Lancet; 2019 Jun; 393(10189):2428-2438. PubMed ID: 31056293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.